Inicio › Cáncer de ovario › Virginia › Arlington
Ensayos clínicos de Cáncer de ovario en Arlington, VA
46 estudios para Cáncer de ovario buscan participantes en centros de Arlington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
The Vanguard Study: Testing a New Way to Screen for Cancer
ReclutandoSe aceptan voluntarios sanos
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- Inova Fair Oaks Hospital, Fairfax · A 11 mi de distancia
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Inova Fairfax Hospital, Falls Church · A 4 mi de distancia
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
ReclutandoFase 1/2
- Research Site, Fairfax · A 11 mi de distancia
A Study of PHST001 in Advanced Solid Tumors
ReclutandoFase 1
- NEXT Oncology - Virginia, Fairfax · A 11 mi de distancia
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- NEXT Virginia, Fairfax · A 11 mi de distancia
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
ReclutandoFase 2
- Next Virginia /ID# 279684, Fairfax · A 11 mi de distancia
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
ReclutandoFase 1
- Site 04, Fairfax · A 11 mi de distancia
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
ReclutandoFase 1
- Next Virginia /ID# 278607, Fairfax · A 11 mi de distancia
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
ReclutandoFase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · A 11 mi de distancia
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ReclutandoFase 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
Study of AVZO-021 in Patients With Advanced Solid Tumors
ReclutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · A 11 mi de distancia
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
ReclutandoFase 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · A 11 mi de distancia
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
ReclutandoFase 1/2
- NEXT Oncology, Fairfax · A 11 mi de distancia
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
ReclutandoFase 3
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
ReclutandoFase 2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
ReclutandoFase 1/2
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- Next Oncology Virginia, Fairfax · A 11 mi de distancia
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
ReclutandoFase 1
- NEXT Oncology, Fairfax · A 11 mi de distancia
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
ReclutandoFase 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · A 11 mi de distancia
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
ReclutandoFase 1
- Inova Schar Cancer Institute, Falls Church · A 4 mi de distancia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ReclutandoFase 1
- Normunity Investigational Site, Fairfax · A 11 mi de distancia
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Reclutando
- Inova Fairfax Hospital, Falls Church · A 4 mi de distancia
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- Inova Fair Oaks Hospital, Fairfax · A 11 mi de distancia
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Clinical Trial Site, Fairfax · A 11 mi de distancia
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ReclutandoFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
ReclutandoFase 2
- 522, Fairfax · A 11 mi de distancia
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · A 11 mi de distancia
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- NEXT, Fairfax · A 11 mi de distancia
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
ReclutandoFase 3
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
ReclutandoFase 1
- NEXT Oncology, Fairfax · A 11 mi de distancia
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
ReclutandoFase 1
- Dren Investigational Site, Fairfax · A 11 mi de distancia
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
ReclutandoFase 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Más información sobre Cáncer de ovario en MedlinePlus
Ensayos de Cáncer de ovario en otras ciudades
- Houston, TX89 estudios
- New York City, NY69 estudios
- Boston, MA61 estudios
- Los Angeles, CA50 estudios
- Nashville, TN49 estudios
- Philadelphia, PA44 estudios
- Columbus, OH39 estudios
- St. Louis, MO38 estudios
- Chicago, IL36 estudios
- San Antonio, TX31 estudios
- Cleveland, OH30 estudios
- Pittsburgh, PA30 estudios
Otros estudios en Arlington
- Cáncer de pulmón de células no pequeñas104 estudios
- Cáncer metastásico53 estudios
- Cáncer del colon y del recto52 estudios
- Cáncer (todos los tipos)48 estudios
- Cáncer de seno47 estudios
- Cáncer de pulmón41 estudios
- Cáncer de endometrio39 estudios
- Cáncer de páncreas33 estudios
- Carcinoma de células escamosas de cabeza y cuello26 estudios
- Cáncer de pulmón de células pequeñas23 estudios
- Cáncer de estómago20 estudios
- Cáncer de mama triple negativo20 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.